J7199 HCPCS Level II code: Hemophilia clotting factor, not otherwise classified
J7199 is the HCPCS code for “Hemophilia clotting factor, not otherwise classified” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7199Hemophilia clotting factor, not otherwise classified
Short description: Hemophilia clot factor noc
HCPCS · United States
Medicare details
The indicators CMS publishes with J7199 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2000
Where J7199 sits
- 1J codesDrugs administered other than orally
- 2Active code J7199Hemophilia clotting factor, not otherwise classified
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7199 mean?
J7199 is the HCPCS code for “Hemophilia clotting factor, not otherwise classified” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7199?
CMS lists J7199’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7199
All J codesJ7193Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.J7194Factor ix, complex, per i.u.J7195Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specifiedJ7196Injection, antithrombin recombinant, 50 i.u.J7197Antithrombin iii (human), per i.u.J7198Anti-inhibitor, per i.u.J7200Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iuJ7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iuJ7204Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iuJ7205Injection, factor viii fc fusion protein (recombinant), per iu